Collaborators

Mayo Clinic and Mayo Cancer Center, Minnesota USA

Nuffield Department of Population Health University of Oxford, Oxford, UK

National Cancer Institute (NCI) at the National Institutes of Health (NIH), Maryland USA

Albert Einstein College of Medicine of Yeshiva University, New York USA

Channing Laboratory, Brigham and Women’s Hospital / Harvard Medical School, Massachusetts USA

National Cancer Institute of Canada Clinical Trial Group (NCIC CTG), Ontario Canada

The University of Texas, MD Anderson Cancer Center, Texas USA

University of Hawai’i System, Hawai'i USA

American Cancer Society, Georgia USA

Fred Hutchinson Cancer Research Center, Washington USA

University of Pennsylvania School of Medicine, Pennsylvania USA

Johns Hopkins Bloomberg School of Public Health, Maryland USA

Pfizer USA

Montreal General Hospital of McGill University, Quebec, Canada

Prostate Centre, Vancouver General Hospital, British Columbia Canada

Cancer prevention and Genetics institute of Europe, Italy

Institute of Medical Science, University of Toronto, Ontario, Canada

Clinical Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense C. Denmark

German Breast Group, Medical Science,  Forschungs Gmbh, Neu-Isenburg, Germany

Food Science and Nutrition, University of Minnesota, Minnesota USA

Institute of Urology, Huashan Hospital, Fudan University, Shaghai, China 200040

School of Public Health and Health Sciences, University of Massachusetts, Massachusetts USA

The International Agency for Research on Cancer (IARC), Lyon, France

University of North Carolina at Chapel Hill, Chapel Hill, NC, USA